The largest community of pharma leaders

Platelet BioGenesis Appoints Biotech Industry Veteran Sam Rasty, Ph.D., as President and Chief Executive Officer

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Platelet BioGenesis (PBG), the leader in stem cell-derived, on-demand human platelets (PLTs+™) and platelet-based therapeutics, announced today the hiring of Sam Rasty, Ph.D., as President and CEO. Dr. Rasty was most recently the Chief Operating Officer of Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, where he played a key role in transforming Homology from a private startup to an established public company. He will help drive the strat..



Recent Articles